Table 2

Prevalence of GP care planning, medicine use for mental health and pain, and back pain across clusters

Care plans and medicine useGP managed cluster, younger n=979GP managed cluster, older n=695Psychiatrist managed cluster n=320GP physiotherapy cluster n=159GP exercise physiology cluster n=133P value
Average number of comorbidities* n (SD)2 (1.9)4 (2.3)5 (2.6)3 (2.4)4 (2.5)<0.0001
Back pain requiring hospital admission, % (95% CI)10 (9 to 12)13 (11 to 16)31 (26 to 36)26 (19 to 33)17 (10 to 23)<0.0001
GP mental health consultations,
% (95% CI)
12 (10 to 14)7 (5 to 9)24 (20 to 29)14 (8 to 19)10 (5 to 15)<0.0001
GP care plans,
% (95% CI)
15 (13 to 18)27 (23 to 30)27 (22 to 32)28 (21 to 35)32 (24 to 40)<0.0001
Antidepressants,
% (95% CI)
44 (41 to 47)53 (50 to 57)69 (64 to 74)51 (43 to 59)51 (43 to 60)<0.0001
Antianxiety agents,
% (95% CI)
21 (18 to 24)15 (12 to 17)58 (53 to 64)24 (17 to 31)23 (16 to 31)<0.0001
Antipsychotics,
% (95% CI)
16 (14 to 18)12 (9 to 14)47 (41 to 52)18 (12 to 24)16 (10 to 22)<0.0001
Mood stabilisers,
% (95% CI)
7 (5 to 8)4 (2 to 5)18 (13 to 22)6 (2 to 10)8 (3 to 12)<0.001
Propranolol,
% (95% CI)
2 (1 to 3)2 (1 to 3)5 (2 to 7)<26 (2 to 10)0.0095
Clonidine, % (95% CI)<2<23 (1 to 5)<200.0012
Prazosin, % (95% CI)5 (3 to 6)5 (3 to 6)19 (15 to 24)10 (5 to 15)5 (1 to 9)<0.001
Opioids,% (95% CI)14 (12 to 16)17 (14 to 20)49 (44 to 55)36 (29 to 44)25 (17 to 32)<0.0001
Non-steroidal anti-inflammatory agents, % (95% CI)21 (19 to 24)36 (32 to 39)44 (39 to 50)50 (42 to 58)46 (37 to 54)<0.0001
Paracetamol,
% (95% CI)
7 (5 to 9)23 (20 to 26)21 (17 to 26)18 (12 to 24)22 (15 to 29)<0.0001
Gabapentin or pregabalin for neuropathic pain, % (95% CI)8 (6 to 9)8 (6 to 10)24 (19 to 28)22 (16 to 29)11 (6 to 17)<0.0001
  • *Number of comorbidities measured by prescription dispensing records using Rx-Risk.11

  • GP, general practitioner.